Efficacy, Tolerability And Safety Of A Range Of Doses Of An Orally Inhaled, Particle Engineered, Drug-Only, Suspension Of Glycopyrronium Bromide In Male And Female Patients With Moderate Or Severe Chronic Obstructive Pulmonary Disease (COPD)